Jielun ZhuCFA, CFO, Executive Director at I-Mab Biopharma Co., Ltd
Jielun Zhu earned his MBA from Harvard Business School with
distinction and B.A. degree with honors from Wesleyan University. He is
also a CFA charter holder.
Mr. Zhu has over 15 years of experience working across investment
banking and strategy consulting for global and regional healthcare
Immediately prior to joining I-Mab, Mr. Zhu was Managing Director and
Asia Head of Healthcare Investment Banking and Capital Markets in
Hong Kong for Jefferies Group LLC. At Jefferies, he led many highprofile
IPO, M&A and other strategic transactions for biotechnology and
other healthcare clients in the Greater China region and beyond. Before
Jefferies, he worked for Deutsche Bank in its Hong Kong office as a
senior member of the healthcare coverage team and for UBS AG in Hong
Kong prior to that. Before investment banking, Mr. Zhu was a strategy
consultant in Boston serving clients in the pharmaceutical and
biotechnology industry in the U.S.